Lord, Abbett & Co’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,248,586
| Closed | -$31.6M | – | 595 |
|
|
2023
Q2 | $31.6M | Buy |
1,248,586
+1,016,810
| +439% | +$25.7M | 0.11% | 256 |
|
|
2023
Q1 | $7.47M | Buy |
+231,776
| New | +$7.47M | 0.03% | 435 |
|
|
2016
Q2 | – | Sell |
-94,700
| Closed | -$1.65M | – | 935 |
|
|
2016
Q1 | $1.65M | Sell |
94,700
-515,068
| -84% | -$8.99M | 0.01% | 845 |
|
|
2015
Q4 | $20.8M | Buy |
609,768
+410,224
| +206% | +$14M | 0.06% | 417 |
|
|
2015
Q3 | $5.94M | Sell |
199,544
-1,822
| -0.9% | -$54.2K | 0.02% | 699 |
|
|
2015
Q2 | $6.44M | Buy |
+201,366
| New | +$6.44M | 0.02% | 729 |
|
|
2014
Q4 | – | Sell |
-278,607
| Closed | -$5.39M | – | 995 |
|
|
2014
Q3 | $5.39M | Buy |
278,607
+77,924
| +39% | +$1.51M | 0.01% | 734 |
|
|
2014
Q2 | $6.82M | Buy |
200,683
+76,783
| +62% | +$2.61M | 0.02% | 735 |
|
|
2014
Q1 | $3.9M | Buy |
+123,900
| New | +$3.9M | 0.01% | 832 |
|